Maternal serum concentration of anti-Müllerian hormone is a better predictor than basal follicle stimulating hormone of successful blastocysts development during IVF treatment.

<h4>Background</h4>The conditions of diminished ovarian reserve and primary ovarian insufficiency, characterized by poor fertility outcomes, currently comprise a major challenge in reproductive medicine, particularly in vitro fertilization. Currently in the IVF industry, blastocyst devel...

Full description

Bibliographic Details
Main Authors: Sheela Sadruddin, Brian Barnett, Lowell Ku, Dara Havemann, Sara Mucowski, Richard Herrington, Warren Burggren
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0239779